Black Diamond Therapeutics, Inc. (BDTX)
Total Valuation
BDTX has a market cap or net worth of $263.24 million. The enterprise value is $153.21 million.
Market Cap | 263.24M |
Enterprise Value | 153.21M |
Important Dates
The last earnings date was Tuesday, March 12, 2024, before market open.
Earnings Date | Mar 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
BDTX has 51.72 million shares outstanding. The number of shares has increased by 21.00% in one year.
Shares Outstanding | 51.72M |
Shares Change (YoY) | +21.00% |
Shares Change (QoQ) | +1.52% |
Owned by Insiders (%) | 2.59% |
Owned by Institutions (%) | 94.18% |
Float | 35.93M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.26 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.82, with a Debt / Equity ratio of 0.19.
Current Ratio | 6.82 |
Quick Ratio | n/a |
Debt / Equity | 0.19 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -76.40% and return on invested capital (ROIC) is -62.24%.
Return on Equity (ROE) | -76.40% |
Return on Assets (ROA) | -56.20% |
Return on Capital (ROIC) | -62.24% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.53M |
Employee Count | 54 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +174.05% in the last 52 weeks. The beta is 2.65, so BDTX's price volatility has been higher than the market average.
Beta (1Y) | 2.65 |
52-Week Price Change | +174.05% |
50-Day Moving Average | 4.29 |
200-Day Moving Average | 3.33 |
Relative Strength Index (RSI) | 56.40 |
Average Volume (30 Days) | 604,267 |
Short Selling Information
The latest short interest is 1.81 million, so 3.50% of the outstanding shares have been sold short.
Short Interest | 1.81M |
Short Previous Month | 1.78M |
Short % of Shares Out | 3.50% |
Short % of Float | 5.05% |
Short Ratio (days to cover) | 2.78 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -86.46M |
Pretax Income | -82.44M |
Net Income | -82.44M |
EBITDA | -82.01M |
EBIT | -82.44M |
Earnings Per Share (EPS) | -$1.88 |
Balance Sheet
The company has $132.22 million in cash and $22.19 million in debt, giving a net cash position of $110.04 million or $2.13 per share.
Cash & Cash Equivalents | 132.22M |
Total Debt | 22.19M |
Net Cash | 110.04M |
Net Cash Per Share | $2.13 |
Equity / Book Value | 116.74M |
Book Value Per Share | 2.26 |
Working Capital | 114.39M |
Cash Flow
In the last 12 months, operating cash flow was -$66.72 million and capital expenditures $62,000, giving a free cash flow of -$66.66 million.
Operating Cash Flow | -66.72M |
Capital Expenditures | 62,000 |
Free Cash Flow | -66.66M |
FCF Per Share | -$1.52 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BDTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -21.00% |
Shareholder Yield | -21.00% |
Earnings Yield | -31.32% |
FCF Yield | -25.32% |
Analyst Forecast
The average price target for BDTX is $10.75, which is 112.03% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $10.75 |
Price Target Difference | 112.03% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |